LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)



      Previous studies showing that smaller low-density lipoprotein (LDL) size is associated with greater atherosclerotic risk did not adequately control for small and large LDL particle correlation.

      Methods and results

      We studied the association of lipoproteins measured by proton nuclear magnetic resonance spectroscopy with carotid intima-media thickness (IMT) in apparently healthy individuals (N = 5538, 38% White, 28% African American, 22% Hispanic, 12% Chinese). Small and large LDL particle concentrations (LDL-p) were inversely correlated (r = −0.63, P < 0.0001). Controlling for risk factors but not for LDL subclass correlation, LDL size and small LDL-p separately were associated with IMT (−20.9 and 31.7 μm change in IMT per 1-S.D., respectively, both P < 0.001), but large LDL-p was not (4.9 μm, P = 0.27). When LDL subclasses were included in the same model, large and small LDL-p were both associated with IMT (36.6 and 52.2 μm higher IMT per 1-S.D., respectively, both P < 0.001; 17.7 and 11.6 μm per 100 nmol/L, respectively). LDL size was not significant after accounting for LDL subclasses and risk factors (P = 0.10).


      Both LDL subclasses were significantly associated with subclinical atherosclerosis, with small LDL confounding the association of large LDL with atherosclerosis. Future studies of LDL size should account for the strong inverse correlation of LDL subclasses.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kuller L.
        • Arnold A.
        • Tracy R.
        • et al.
        Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study.
        Arterioscler Thromb Vasc Biol. 2002; 22: 1175-1180
        • Blake G.J.
        • Otvos J.D.
        • Rifai N.
        • Ridker P.M.
        Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women.
        Circulation. 2002; 106: 1930-1937
        • Rosenson R.S.
        • Otvos J.D.
        • Freedman D.S.
        Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial.
        Am J Cardiol. 2002; 90: 89-94
        • Berneis K.K.
        • Krauss R.M.
        Metabolic origins and clinical significance of LDL heterogeneity.
        J Lipid Res. 2002; 43: 1363-1379
        • Sacks F.M.
        • Campos H.
        Clinical review 163: cardiovascular endocrinology: low-density lipoprotein size and cardiovascular disease: a reappraisal.
        J Clin Endocrinol Metab. 2003; 88: 4525-4532
        • Cromwell W.C.
        • Otvos J.D.
        Low-density lipoprotein particle number and risk for cardiovascular disease.
        Curr Atheroscler Rep. 2004; 6: 381-387
        • Otvos J.D.
        Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy.
        Clin Lab. 2002; 48: 171-180
        • O’Leary D.H.
        • Polak J.F.
        Intima-media thickness: a tool for atherosclerosis imaging and event prediction.
        Am J Cardiol. 2002; 90: 18L-21L
        • Bild D.E.
        • Bluemke D.A.
        • Burke G.L.
        • et al.
        Multi-Ethnic Study of Atherosclerosis: objectives and design.
        Am J Epidemiol. 2002; 156: 871-881
      1. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—The Evidence Report. National Institutes of Health. Obes Res 1998;6(Suppl 2):51S–209S.

        • O’Leary D.H.
        • Polak J.F.
        • Kronmal R.A.
        • et al.
        Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group.
        Stroke. 1996; 27: 224-231
        • Schaefer E.J.
        • McNamara J.R.
        • Tayler T.
        • et al.
        Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.
        Am J Cardiol. 2002; 90: 689-696
        • Otvos J.D.
        • Jeyarajah E.J.
        • Cromwell W.C.
        Measurement issues related to lipoprotein heterogeneity.
        Am J Cardiol. 2002; 90: 22i-29i
        • Freedman D.S.
        • Otvos J.D.
        • Jeyarajah E.J.
        • et al.
        Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
        Arterioscler Thromb Vasc Biol. 1998; 18: 1046-1053
        • Festa A.
        • Williams K.
        • Hanley A.J.
        • et al.
        Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
        Circulation. 2005; 111: 3465-3472
        • St-Pierre A.C.
        • Cantin B.
        • Dagenais G.R.
        • et al.
        Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study.
        Arterioscler Thromb Vasc Biol. 2005; 25: 553-559
        • Lamarche B.
        • Tchernof A.
        • Moorjani S.
        • et al.
        Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.
        Circulation. 1997; 95: 69-75
        • Rajman I.
        • Kendall M.J.
        • Cramb R.
        • et al.
        Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men.
        Atherosclerosis. 1996; 125: 231-242
        • Liu M.L.
        • Ylitalo K.
        • Nuotio I.
        • et al.
        Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families.
        Stroke. 2002; 33: 1255-1260
        • Stampfer M.J.
        • Krauss R.M.
        • Ma J.
        • et al.
        A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.
        JAMA. 1996; 276: 882-888
        • Gardner C.D.
        • Fortmann S.P.
        • Krauss R.M.
        Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.
        JAMA. 1996; 276: 875-881
        • Hulthe J.
        • Wiklund O.
        • Bondjers G.
        • Wikstrand J.
        LDL particle size in relation to intima-media thickness and plaque occurrence in the carotid and femoral arteries in patients with hypercholesterolaemia.
        J Intern Med. 2000; 248: 42-52
        • Tzou W.S.
        • Douglas P.S.
        • Srinivasan S.R.
        • et al.
        Advanced lipoprotein testing does not improve identification of subclinical atherosclerosis in young adults: the Bogalusa Heart Study.
        Ann Intern Med. 2005; 142: 742-750
        • Campos H.
        • Roederer G.O.
        • Lussier-Cacan S.
        • Davignon J.
        • Krauss R.M.
        Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease.
        Arterioscler Thromb Vasc Biol. 1995; 15: 1043-1048
        • Campos H.
        • Moye L.A.
        • Glasser S.P.
        • Stampfer M.J.
        • Sacks F.M.
        Low-density lipoprotein size, pravastatin treatment, and coronary events.
        JAMA. 2001; 286: 1468-1474
        • Otvos J.D.
        • Collins D.
        • Freedman D.S.
        • et al.
        LDL and HDL particle subclasses predict coronary events and are changed favorably by gemfibrozil therapy in the veterans affairs HDL intervention trial (VA-HIT).
        Circulation. 2006; 113: 1556-1563
        • Campos H.
        • Arnold K.S.
        • Balestra M.E.
        • Innerarity T.L.
        • Krauss R.M.
        Differences in receptor binding of LDL subfractions.
        Arterioscler Thromb Vasc Biol. 1996; 16: 794-801
        • Tribble D.L.
        • Rizzo M.
        • Chait A.
        • et al.
        Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins.
        Am J Med. 2001; 110: 103-110
        • Patsch W.
        • Ostlund R.
        • Kuisk I.
        • Levy R.
        • Schonfeld G.
        Characterization of lipoprotein in a kindred with familial hypercholesterolemia.
        J Lipid Res. 1982; 23: 1196-1205
        • Rudel L.L.
        • Parks J.S.
        • Hedrick C.C.
        • Thomas M.
        • Williford K.
        Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates. Role of cholesterol and fatty acids.
        Prog Lipid Res. 1998; 37: 353-370